该词条未找到_海词词典

您要查找的是不是：

major urinary protein 严重的尿蛋白, 较多的尿蛋白
Objective To distinguish the sources of the proteinuria by analyzing the compositions of the urinary protein. 目的分析尿蛋白成分来鉴别蛋白尿来源。
Results: Fenugreek treatment decreased urinary protein excretion,serum creatinine and blood urea nitrogen in dia... 结果:胡芦巴能减少尿蛋白排泄率,降低血肌酐和尿素氮水平,减轻肾脏病变程度。
There was no correlation between artery blood pressure and RCBF or urinary protein. 平均动脉压在整个病程中与肾皮质血流无显著相关。
Conclusion: Elastase is an ideal drug in treating urinary protein in patients... 结论:弹性酶是治疗糖尿病肾病蛋白尿的理想药物。
Objective: To investigate the effects of elastase on urinary protein in diabetic nephropathy. 目的:探讨弹性酶对糖尿病肾病的治疗作用。
The relation between expressions of ED_1 and MCP-1 was positieelycorrelated with 24-hour urinary protein and creatinine clear rate. 相关分析显示: MCP-1、 ED_1平均光密度值与 24 小时尿微量白蛋白、血清肌酐清除率具有显著直线正相关, MCP-1 与 ED_1平均光密度值二者间也具有正相关。
The BG,Bp,BUN,Cr and urinary protein excretion rate of 21 NIDDM patients with proteinuria,who were treated for 2 weeks with captopril,were studied. 观察21例伴有蛋白尿的非胰岛素依赖型糖尿病（NIDDM）患者用卡托普利（Captopril）治疗2周前后的尿蛋白排泄率，血糖、血压、血尿素氮（BUN）、血肌酐（Cr）等的变化。
The levels of blood lipid,blood viscosity,blood creatinine (Cr),blood urea nitrogen(BUN) and urinary protein were detected before and after treatment. 治疗前后检测血脂、血粘度、血肌酐（Cr）、血尿素氮（BUN）及尿蛋白。
Urinary protein was significantly reduced in T75 after 2 wk of treatment and was also declined in the other two treatment groups but only after 2 mo. 2周后在T75治疗组尿蛋白显著降低，仅在2月后，其他两个治疗组的尿蛋白降低。
Results: After treatment, the clinical symptoms, urinary protein and immunity improved;the Prednisonum used was lessened obviously. 结果:治疗后患者临床症状、蛋白尿、免疫功能有明显改善,强的松用量显著减少。
Results: MMF could decrease urinary protein, improve renal function and hematuria, therapeutic efficacy were significantly (P<0.05). 结果：霉酚酸酯能降低尿蛋白，减轻血尿，改善肾功。
Urinary podocyte excretion level in IgAN patients is correlated with 24 h urinary protein excretion and specific pathological damages. 足细胞尿排泄的水平与蛋白尿水平呈正相关，与肾脏病理类型也有一定的关系。
Results: At 8th week, kidney weight/body weight (KW/BW) and 24 hours urinary protein count increased significantly in DN model group, compared with control group (P<0.01, P<0.01). 结果8周时糖尿病肾病组肾重/体重比和24小时尿蛋白定量明显增高;与对照组比较有显著性差异(P<0.;01;P<0
After administration of losartan for 2 weeks and 12 weeks, 24-hour urinary protein excretion (24 hUPE), Scr and Ccr were measured, and renal morphology was observed. 分别于2周和12周杀鼠,观察体重、肾重、肾重/体重指数、尿蛋白量(24 h)、Scr、Ccr以及肾组织病理改变;
Before and after therapy the changes in quantitative measurement of 24 hours urinary protein,blood creatinine(Cr),complement C3,C4,and antinuclear antibody(ANA) were detected. 在治疗前后检测 2 4小时尿蛋白定量、血肌酐、C3、C4、抗核抗体 (ANA )的变化。
The analysis can be performed by examining serum or urinary proteins by immunoelectrophoresis. 可用免疫电泳方法进行血清或尿中蛋白的分析。
Blood examination showed leukocytosis, thrombocytopenia, and positive urinary protein, hematuria, urine inside membrane-like manifestations such as renal dysfunction. 血常规检查可见白细胞增多、血小板下降，并有尿蛋白阳性、血尿、尿内出现膜状物等肾功能损害表现。
The change of recur degree , urinary protein, serum albumin, cholesterol , T cell subpopulation , croticosteroid before and after treatment were observed. 观察治疗前后复发次数及尿蛋白、血清白蛋白、胆固醇、T细胞亚群、血清皮质醇的变化。
The original antihyperglycemic therapies were identical.Results: Urinary protein in the treatment group decreased obviously.These changes were not observed in the control group. 结果:弹性酶组糖尿病肾病患者的尿蛋白明显减少,而安慰剂组则无明显改变。